PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This trial will be conducted to explore the biological effects in the skin following
treatment with PEP005 Gel, 0.05% administered for two consecutive days, assessed by
histology.